Search
Detroit, MI Paid Clinical Trials
A listing of 794 clinical trials in Detroit, MI actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
745 - 756 of 794
There are currently 794 clinical trials in Detroit, Michigan looking for participants to engage in research studies. Trials are conducted at various facilities, including Henry Ford Hospital, Henry Ford Health System, Barbara Ann Karmanos Cancer Institute and Wayne State University/Karmanos Cancer Institute. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Irritability Associated with Autism (Children and Adolescents) Study
Recruiting
Join a clinical trial today and take a step toward finding a better solution for you. Earn money for your time and no-cost medical treatment is provided.
Featured Trial
COPD Study
Recruiting
Become part of a clinical trial today and play a role in driving medical research forward, aiding in the discovery of groundbreaking therapies. Get rewarded for your time with monetary compensation and enjoy access to medical treatment at no charge.
Featured Trial
Child/Teen Migraine Study
Recruiting
Sign up for a clinical trial today and contribute to the advancement of medical research, paving the way for innovative treatments. Receive financial compensation for your participation and benefit from complimentary medical care.
Bioinductive Patch for Full-Thickness Rotator Cuff Tears
Recruiting
The purpose of this randomized-controlled study is to compare outcomes of arthroscopic rotator cuff repair augmented with a Bioinductive Implant (study group) to standard arthroscopic rotator cuff repair (control group). The primary outcome of this study is rotator cuff repair integrity (absence of full- or partial-thickness defect) demonstrated on ultrasound at 1-year postoperatively. The investigators hypothesize that the study group will have higher rates of repair integrity demonstrated on u... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/17/2023
Locations: Henry Ford Health, Detroit, Michigan
Conditions: Rotator Cuff Tears, Rotator Cuff Tear Arthropathy
JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
Recruiting
To evaluate the safety and tolerability of JAB-3312 administered in investigational regimens in adult participants with advanced solid tumors.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/16/2023
Locations: Research Site, Detroit, Michigan
Conditions: Solid Tumor, NSCLC
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients
Recruiting
This phase II trial studies the effects of leflunomide in treating African-American and European-American patients with high-risk smoldering multiple myeloma. Leflunomide is used to decrease the body's immune response and may delay the symptoms of multiple myeloma in patients of African-American and European decent.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/15/2023
Locations: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Conditions: Smoldering Plasma Cell Myeloma
Dietary Reporting In The Amyloidoses
Recruiting
The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis.
The main question it aims to answer is:
Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients
Participants will be asked to:
Download the MyFitnessPal application on their smartphone and view an online tutorial
After a week of practice, from weeks 2-9, participants will enter... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/05/2023
Locations: Karmanos Cancer Institute, Detroit, Michigan
Conditions: Amyloidosis
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Recruiting
Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000 men with advanced cancer, including men with mHSPC and M0/M1 CRPC. The goal is to establish a population-based registry and recruit patients across academic and community practices from Australia, Barbados, Brazil, Canada, Ireland, Jamaica, Kenya, Nigeria, Norway, Spain, South Africa, Sweden, Switzerland, the United Kingd... Read More
Gender:
Male
Ages:
21 years and above
Trial Updated:
05/04/2023
Locations: Karmanos Cancer Institute, Detroit, Michigan
Conditions: Prostate Cancer
AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm
Recruiting
This pilot trial studies how well telotristat etiprate works in treating participants with well differentiated neuroendocrine neoplasm that has spread to other places in the body and monitored by carbon C 11 alpha-methyltryptophan (AMT)-emission tomography (PET). Telotristat etiprate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Studying the changes within the tumor cells via AMT-PET may help doctors better understand how tumors respond to treatment w... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/04/2023
Locations: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Conditions: Carcinoid Syndrome, Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Recruiting
The purpose of this study is to establish recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD) and preliminary antitumor activity of ORIC-944 in patients with metastatic prostate cancer.
Gender:
Male
Ages:
18 years and above
Trial Updated:
04/28/2023
Locations: Karmanos, Detroit, Michigan
Conditions: Metastatic Prostate Cancer, Neuroendocrine Prostate Cancer
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Recruiting
The study will investigate the effects of adding carfilzomib to the combination of pomalidomide and dexamethasone in sequential dose escalation cohorts in patients with relapsed or refractory multiple myeloma. This portion of the study is complete.
This study will also investigate the effects of adding daratumumab to the combination of carfilzomib, pomalidomide and dexamethasone.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/26/2023
Locations: Wayne State University - Karmonos Cancer Center, Detroit, Michigan
Conditions: Multiple Myeloma
Longitudinal Neuroimaging in Sturge-Weber Syndrome
Recruiting
In this project the accuracy of a novel, rapid magnetic resonance imaging (MRI) approach to detect brain abnormalities in patients with Sturge-Weber syndrome (SWS) will be tested; this new imaging approach, that can create multiple types of MR images in about 5 minutes, without contrast administration (and sedation even in young children), can be also readily applied in other pediatric brain disorders in the future. The investigators will also study how advanced MRI, including susceptibility-wei... Read More
Gender:
All
Ages:
Between 3 months and 30 years
Trial Updated:
04/24/2023
Locations: Wayne State University / Children's Hospital of Michigan, Detroit, Michigan
Conditions: Sturge-Weber Syndrome
Automated Ultrasound Cardiac Guidance Tool
Recruiting
This research examines echocardiography images taken from cardiac patients in relation to the guidance tool developed
Gender:
All
Ages:
Between 18 years and 120 years
Trial Updated:
04/24/2023
Locations: Wayne University, Detroit, Michigan
Conditions: Ultrasound Imaging
Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery
Recruiting
This project will test the accuracy of a novel diffusion-weighted magnetic resonance imaging (DWMRI) approach using a deep convolutional neural network (DCNN) to predict an optimal resection margin for pediatric epilepsy surgery objectively. Its primary goal is to minimize surgical risk probability (i.e., functional deficit) and maximize surgical benefit probability (i.e., seizure freedom) by precisely localizing eloquent white matter pathways in children and adolescents with drug-resistant foca... Read More
Gender:
All
Ages:
Between 3 years and 19 years
Trial Updated:
04/24/2023
Locations: Wayne State University/Children's Hospital of Michigan, Detroit, Michigan
Conditions: Focal Epilepsy
DOAC in Unusual Site Venous Thrombosis
Recruiting
Unusual site venous thromboembolism (VTE) refers to thrombosis occurring in venous districts outside the veins of the lower extremities and the pulmonary arteries, and includes splanchnic vein thrombosis (SVT), cerebral vein thrombosis (CVT), retinal vein thrombosis, ovarian vein thrombosis, and renal vein thrombosis. The use of the novel direct oral anticoagulants (DOAC), thrombin or factor Xa-inhibitors (such as dabigatran, apixaban, edoxaban, rivaroxaban), in patients with unusual VTE in clin... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/20/2023
Locations: Henry Ford Health System, Detroit, Michigan
Conditions: Splanchnic Vein Thrombosis, Cerebral Vein Thrombosis, Ovarian Vein Thrombosis, Renal Vein Thrombosis, Retinal Vein Thrombosis
745 - 756 of 794